India Biosimilar Cetuximab Go-Ahead: Merck KGaA Wants Data In Public Domain

 
• By Anju Ghangurde

Merck KGaA calls for data on Indian firm Enzene’s biosimilar cetuximab to be made available in the public domain, citing the Helsinki Declaration.

Merck seeks biosimilar cetuximab data be placed in the public domain • Source: Shutterstock

More from India

More from Focus On Asia